Millipore Reports Fourth Quarter and Fiscal Year 2007 Earnings: January 31, 4 p.m. ET

Featured In: Supplier News

By Millipore Thursday, June 3, 2024

Loading...
Company delivers significant increases in profitability and cash flow

BILLERICA, Mass. - January 31, 2024 - Millipore Corporation (NYSE:MIL), a life science leader that provides technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today reported financial results for its fourth quarter and full year ended December 31, 2007.

Revenues for the fourth quarter grew 6 percent, totaling $405.2 million. Excluding a 6 percent benefit from changes in foreign currency, revenues in the fourth quarter were unchanged from the previous year. Excluding changes in foreign currency, Millipore’s Bioscience Division’s revenues grew 6 percent, offsetting a 4 percent decline in revenues from the Company’s Bioprocess Division.

For the full year 2007, revenues rose 22 percent, totaling $1.53 billion. Changes in foreign exchange rates contributed 5 percent to total revenue growth during 2007. Excluding currency rate changes and acquisitions not in the comparable period, Millipore’s total revenue growth in 2007 was 6 percent, which reflects 8 percent growth from its Bioscience Division and 5 percent growth in its Bioprocess Division.

On a GAAP basis, the Company reported fourth quarter net income of $45.1 million, or $0.81 per share, compared to $18.5 million, or $0.34 per share in 2006. Non-GAAP net income grew approximately 15 percent in the fourth quarter to $54.1 million, or $0.98 per share, compared to $46.9 million, or $0.86, in the fourth quarter of 2006. On a pre-tax basis, stock-based compensation expense in the fourth quarter of 2007 was $4.4 million, or $0.06 per share, and is reflected in both GAAP and non-GAAP earnings per share. A reconciliation of GAAP to non-GAAP financial measures is provided in the Company’s financial tables accompanying this press release.

For the full year, Millipore’s GAAP net income grew 41 percent to $136.5 million, or $2.48 per share, compared to $97.0 million, or $1.79 per share in 2006. Non-GAAP net income for 2007 grew 18 percent to $184.8 million, or $3.36 per share. On a pre-tax basis, stock-based compensation expense in 2007 was $16.0 million, or $0.20 per share, and is reflected in both GAAP and non-GAAP earnings per share.

“During 2007, we remained focused on advancing our innovation strategy by creating new alliances and increasing the number of our new product launches,” said Martin Madaus, Chairman & CEO of Millipore. “We generated solid financial performance, with 6 percent organic revenue growth, 16 percent growth in our non-GAAP earnings per share, and $121 million of free cash flow in 2007. This financial performance is the result of our balanced business portfolio and our commitment to driving improvements in profitability and cash flow.

“While we are pleased with our 2007 results overall, our fourth quarter performance was adversely affected by a pronounced slowdown in our Bioprocess business. A few of our largest North American biotech customers are lowering their inventories and reducing their purchases, which is negatively affecting our U.S. sales. We expect the lower level of spending from these customers to continue at least through the first half of 2008. Other than the slowdown in these few accounts, our Bioprocess Division generated double-digit growth from biotech customers in all geographic regions, and we remain confident in the long-term attractiveness of the global biotech industry. Over the next few quarters, we expect that growth in our Bioscience Division will help mitigate the near-term weakness we expect in our Bioprocess business until our largest customers resume more typical purchasing patterns.”

During 2007, Millipore continued to implement its five-year strategic plan designed to accelerate top and bottom-line growth. Three years ago, the Company outlined this strategic plan that included goals for enhancing its revenue growth, increasing its scale, expanding into new markets, and substantially improving its profitability and cash flow. Since 2004, the Company has made significant progress toward achieving these goals, generating compound annual revenue growth of 20 percent, increasing its revenues from $883 million to $1.53 billion, and expanding into new markets through four acquisitions. Additionally, Millipore has increased its non-GAAP operating margins from 16.8 percent in 2004 to 20.3 percent in 2007 and generated $555 million in cash flow from operations over the past three years.

“The successful execution of our strategic initiatives and the achievement of integration cost synergies were significant drivers of the 160 basis points of improvement in non-GAAP operating margin during 2007,” said Charles Wagner, Chief Financial Officer of Millipore. “We also had a strong year of cash flow performance, which enabled us to pay down approximately $200 million of debt. The reduction of our debt will continue to be a significant priority for the Company.”

SOURCE

Join the Discussion
Rate Article: Average 0 out of 5
register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

Research Exchange

Optical Imaging in Stem Cell Research

Jun 1

Developing sensitive, non-invasive technologies to monitor engraftment in vivo is essential to accelerate the clinical implementation of cell therapies.

Standing Up in a Court of Law

Jun 1

Private forensic testing laboratory ensures data integrity with advanced calibration systems.

Simultaneous Measurement of Multiple Signaling Pathways in Human Leukemias Using Flow Cytometry

May 24

Next generation assays will need to be robust and standardized in order to make the transition from a research procedure to a routine clinical assay. Flow cytometry provides a unique and sensitive method to accomplish these requirements.

Automated Forensic DNA Methods: Relieving the Pain of Validation

Apr 21

Automation can increase a forensics lab's sample processing capacity, but it can also add to the complexity of system verification and validation.

Step up to the MIQE

Mar 30

Over the years, polymerase chain reaction (PCR) has evolved into a readily automated, high throughput quantitative technology. Real-time quantitative PCR (qPCR) has become the industry standard for the detection and quantification of nucleic acids for multiple application, including quantification of RNA levels. But a lack of consensus among researchers on how to best perform and interpret qPCR experiments presents a major hurdle for advancement of the technology. This problem is exacerbated by insufficient experimental detail in published work, which impedes the ability of others to accurately evaluate or replicate reported results.

Fast Optimization of a Multiplex Influenza Identification Panel Using a Thermal Gradient

Mar 30

The year 2009 was marked by the emergence of a novel influenza A (H1N1) virus that infects humans. There is a need to identify the different strains of influenza virus for purposes of monitoring the H1N1 strain pandemic and for other epidemiological and scientific purposes.

Advantages of Monolithic Laser Combiner Technology in Confocal Microscopy Systems

Jan 6

Fluorescence microscopy techniques require a reliable light source at the desired wavelength or wavelengths, with minimal downtime for maintenance and alignment. Lasers are a popular light source, although the alignment and upkeep of laser combiners is a time-consuming prospect for many users.

Size-Exclusion Chromatography for Purification of Biomolecules

Dec 2 2009

Size-exclusion chromatography (SEC) is a popular method to separate biomolecules based on their size. Primarily, it is applied to the separation of biopolymers such as proteins and nucleic acids, i.e. water-soluble polymers.

Using the Tecan Genesis Workstation to Automate a Cytometric Bead Array (CBA) Immunoassay

Mar 11

The poster describe the process involved in automating a Cytometric Bead Array (CBA) immunoassay developed to measure relative concentrations of serum antibodies against Tetanus (TT), Sperm Whale Myoglobin (SWM) and Keyhole Limpet Hemocyanin (KLH) in KLH-immunized volunteers.

Ensuring Quality in Assays Performed with Automated Liquid Handlers

Feb 2

The focus of this presentation is to highlight the need of ensuring quality in important assays performed with automated liquid handlers. Nearly all assays performed within a laboratory are volume-dependent. In turn, all concentrations of biological and chemical components in these assays, as well as the associated dilution protocols, are volume-dependent. Because analyte concentration is volume-dependent, an assay’s results might be falsely interpreted if liquid handler variability and inaccuracies are unknown or if the system(s) go unchecked for a long period.

Inkjet System for Protein Crystallography

Feb 1

X-ray crystallography is used routinely by scientists to obtain the three dimensional structure of a biological molecule of interest.Such information can be used to determine how a pharmaceutical interacts with a protein target and what changes might improve functionality. However, the crystallization of macromolecules still remains a serious hindrance in structural determination despite impressive advances in screening methods and technologies.

Attention Deficit & Hyperactivity in a Drosophila Memory Mutant

Attention Deficit & Hyperactivity in a Drosophila Memory Mutant

Nov 9 2009

Action selection is modulated by external stimuli either directly or via memory retrieval. In a constantly changing environment, animals have evolved attention-like processes to effectively filter the incoming sensory stream. These attention-like processes, in turn, are modulated by memory. The neurobiological nature of how attention, action selection and memory are inter-connected is unknown. We describe here new phenotypes of the memory mutant radish in the fruit fly Drosophila.

Prokariotic Cell Collection in Denmark

Nov 6 2009

I would like to know about a prokariotic cell collection in Denmark. Is there a cell bank in this country? I need a Lactobacillus strain for a fermentation assay and this information about the bank is very helpful for me.

Request for Entries

Oct 16 2009

Ask the Experts is your chance to get the answers to questions on applications, materials, methods, processes, and technologies. Email you question to bst_web@advantagemedia.com, and the editors of Bioscience Technology will find an appropriate expert to answer it. Watch this space in the future to see the questions your colleagues are posting.

STAY INFORMED: SUBSCRIBE TO

Magazine and E-mail Newsletters

Loading...
E-mail:   

MULTIMEDIA

Video:

Neuroscience Diseases of The Brain and How The Mind Emerges

Neuroscience Diseases of The Brain and How The Mind Emerges

Nov 8 2009

Dennis Choi, director of Emory Universitys Neuroscience Center, is renowned for his groundbreaking research on brain and spinal cord injury.

Podcasts:

Allen Institute for Brain Research

Allen Institute for Brain Research

Oct 14 2009

Discussed in this interview are both the mouse brain project and the human cortex project with an emphasis on the importance of these projects to neuroscience research.

Information: